HIV gp120 and CD4 Binding: The Key to Viral Entry
The HIV envelope glycoprotein gp120 is the viral ligand that binds the host cell receptor CD4 on helper T lymphocytes (and macrophages, dendritic cells). This interaction initiates the entry cascade.
Stepwise Binding Process
- gp120-CD4 binding: gp120 (on trimeric Env spike) binds CD4 domain 1 → conformational change in gp120.
- Coreceptor exposure: The CD4-induced conformation reveals the V3 loop, enabling binding to a chemokine coreceptor (CCR5 for R5-tropic strains; CXCR4 for X4-tropic).
- gp41 activation: Coreceptor binding triggers gp41 (transmembrane subunit) to extend its fusion peptide into the host membrane.
- Membrane fusion: gp41 refolds into a six-helix bundle, pulling viral and cellular membranes together → fusion pore → viral core entry.
Therapeutic Targets
- CD4 attachment inhibitors: Fostemsavir (binds gp120, blocks CD4 interaction).
- CCR5 antagonists: Maraviroc (blocks coreceptor).
- Fusion inhibitors: Enfuvirtide (T-20, binds gp41 HR1, prevents six-helix bundle).
- Broadly neutralizing antibodies (bNAbs): Target conserved epitopes on gp120/gp41 (e.g., VRC01, 3BNC117).
Significance
The gp120-CD4 interaction is the gateway to infection; its plasticity allows immune evasion but also offers multiple intervention points.
HIV & AIDS - Related Articles
- HIV Transmission Myths: Mosquito Bites and Ingestion Cannot Spread HIV
- HIV and Normal Blood Tests: Can HIV Still Be Present?
- Understanding the Progression of HIV to AIDS: What You Need to Know
- Managing HIV/AIDS Treatment Side Effects: A Comprehensive Guide
- Why People with AIDS Develop Opportunistic Infections
- HIV Transmission Myths: Sharing Underwear Does Not Transmit HIV
- HIV Transmission: Five Main Routes and Prevention
